Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

8.42
Delayed Data
As of 12:46pm ET
 -0.06 / -0.71%
Today’s Change
5.50
Today|||52-Week Range
13.18
-19.50%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close8.48
Today’s open8.40
Day’s range8.28 - 8.45
Volume95,074
Average volume (3 months)371,874
Market cap$335.9M
Dividend yield--
Data as of 12:46pm ET, 05/03/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)-57.39%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book4.70

Competitors

 Today’s
change
Today’s
% change
LJPCLa Jolla Pharmaceuti...-0.42-2.22%
RIGLRigel Pharmaceutical...-0.07-2.46%
NUTRNutraceutical Intern...-0.16-0.68%
CDTXCidara Therapeutics ...-0.67-4.79%
Data as of 12:43pm ET, 05/03/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs